Citations

Clear

67 citation(s) found for "Kocher, Jean‐Pierre".

PatternCNV: a versatile tool for detecting copy number changes from exome sequencing data
Wang, Chen , Evans, Jared M., Bhagwate, Aditya , Prodduturi, Naresh, Sarangi, Vivekananda , Middha, Mridu , Sicotte, Hugues , Vedell, Peter T. , Hart, Steven N. , Oliver, Gavin R. , Kocher, Jean‐Pierre , Maurer, Matthew J. , Novak, Anne J. , Cerhan, James R. , Asmann, Yan W. , Bhagwate, Aditya V., Slager, Susan L. , Maurer, Matthew , Cerhan, James R , Wang, Chen , Hart, Steven N

Mayo Clinic

Bioinformatics | May 30, 2014 | Volume: 30 | Issue: 18 | Pages: 2678-2680

10.1093/bioinformatics/btu363 | PMID 24876377 Get It

Abstract Motivation: Exome sequencing (exome-seq) data, which are typically used for calling exonic mutations, have also been utilized in detecting DNA copy number variations (CNVs). Despite the existence of several CNV detection tools, there is still a great need for a sensitive and an accurate CNV-calling algorithm with built-in QC steps, and does not require a paired reference for each sample. Results: We developed a novel method named PatternCNV, which (i) accounts for the read coverage variations between exons while leveraging the consistencies of this variability across different samples; (ii) reduces alignment BAM files to WIG format and therefore greatly accelerates computation; (iii) incorporates multiple QC measures designed to identify outlier samples and batch effects; and (iv) provides a variety of visualization options including chromosome, gene and exon-level views of CNVs, along with a tabular summarization of the exon-level CNVs. Compared with other CNV-calling algorithms using data from a lymphoma exome-seq study, PatternCNV has higher sensitivity and specificity. Availability and implementation: The software for PatternCNV is implemented using Perl and R, and can be used in Mac or Linux environments. Software and user manual are available at http://bioinformaticstools.mayo.edu/research/patterncnv/ , and R package at https://github.com/topsoil/patternCNV/ . Contact: Asmann.Yan@mayo.edu Supplementary information: Supplementary data are available at Bioinformatics online.
Transcriptional atlas of cardiogenesis maps congenital heart disease interactome
Martinez‐Fernandez, Almudena , Hartjes, Katherine A., Kocher, Jean‐Pierre , Olson, Timothy M. , Nelson, Timothy J., Martinez-Fernandez, Almudena, Xing, Li , Terzic, André , Nelson, Timothy J. , Olson, Timothy M

Mayo Clinic

Physiological Genomics | May 7, 2014 | Volume: 46 | Issue: 13 | Pages: 482-495

10.1152/physiolgenomics.00015.2014 | PMID 24803680 Get It

Mammalian heart development is built on highly conserved molecular mechanisms with polygenetic perturbations resulting in a spectrum of congenital heart diseases (CHD). However, knowledge of cardiogenic ontogeny that regulates proper cardiogenesis remains largely based on candidate-gene approaches. Mapping the dynamic transcriptional landscape of cardiogenesis from a genomic perspective is essential to integrate the knowledge of heart development into translational applications that accelerate disease discovery efforts toward mechanistic-based treatment strategies. Herein, we designed a time-course transcriptome analysis to investigate the genome-wide dynamic expression landscape of innate murine cardiogenesis ranging from embryonic stem cells to adult cardiac structures. This comprehensive analysis generated temporal and spatial expression profiles, revealed stage-specific gene functions, and mapped the dynamic transcriptome of cardiogenesis to curated pathways. Reconciling known genetic underpinnings of CHD, we deconstructed a disease-centric dynamic interactome encoded within this cardiogenic atlas to identify stage-specific developmental disturbances clustered on regulation of epithelial-to-mesenchymal transition (EMT), BMP signaling, NF-AT signaling, TGFb-dependent EMT, and Notch signaling. Collectively, this cardiogenic transcriptional landscape defines the time-dependent expression of cardiac ontogeny and prioritizes regulatory networks at the interface between health and disease.
Clinical Proteome Informatics Workbench Detects Pathogenic Mutations in Hereditary Amyloidoses
Dasari, Surendra , Theis, Jason D. , Vrana, Julie A. , Zenka, Roman M. , Zimmermann, Michael T. , Kocher, Jean‐Pierre , Highsmith, W. Edward, Kurtin, Paul J. , Vrana, Julie A. , Doǧan, Ahmet , Zimmermann, Michael T

Mayo Clinic

Journal of Proteome Research | March 21, 2014 | Volume: 13 | Issue: 5 | Pages: 2352-2358

10.1021/pr4011475 | PMID 24650283 Get It

The Biological Reference Repository (BioR): a rapid and flexible system for genomics annotation
Kocher, Jean-Pierre A., Quest, Daniel, Meiners, Michael A., Moore, Raymond M. , Hossain, Asif, Hart, Steven N. , Dinu, Valentin , Quest, Daniel J, Duffy, Patrick, Rider, David, Duffy, Patrick Emmet , Rider, David A. , Dinu, Valentin , Hart, Steven N , Moore, Raymond

Mayo Clinic

Bioinformatics | March 12, 2014 | Volume: 30 | Issue: 13 | Pages: 1920-1922

10.1093/bioinformatics/btu137 | PMID 24618464 Get It

Abstract Motivation: The Biological Reference Repository (BioR) is a toolkit for annotating variants. BioR stores public and user-specific annotation sources in indexed JSON-encoded flat files (catalogs). The BioR toolkit provides the functionality to combine and retrieve annotation from these catalogs via the command-line interface. Several catalogs from commonly used annotation sources and instructions for creating user-specific catalogs are provided. Commands from the toolkit can be combined with other UNIX commands for advanced annotation processing. We also provide instructions for the development of custom annotation pipelines. Availability and implementation: The package is implemented in Java and makes use of external tools written in Java and Perl. The toolkit can be executed on Mac OS X 10.5 and above or any Linux distribution. The BioR application, quickstart, and user guide documents and many biological examples are available at http://bioinformaticstools.mayo.edu . Contact: Kocher.JeanPierre@mayo.edu Supplementary information: Supplementary data are available at Bioinformatics online.
Murine Leukemia Virus Uses NXF1 for Nuclear Export of Spliced and Unspliced Viral Transcripts
Sakuma, Toshie, Davila, Jaime , Malcolm, Jessica A., Kocher, Jean-Pierre A., Tonne, Jason M., Ikeda, Yasuhiro , Davila, Jaime I

Mayo Clinic

Journal of Virology | January 30, 2014 | Volume: 88 | Issue: 8 | Pages: 4069-4082

10.1128/jvi.03584-13 | PMID 24478440 Get It

ABSTRACT Intron-containing mRNAs are subject to restricted nuclear export in higher eukaryotes. Retroviral replication requires the nucleocytoplasmic transport of both spliced and unspliced RNA transcripts, and RNA export mechanisms of gammaretroviruses are poorly characterized. Here, we report the involvement of the nuclear export receptor NXF1/TAP in the nuclear export of gammaretroviral RNA transcripts. We identified a conserved cis -acting element in the pol gene of gammaretroviruses, including murine leukemia virus (MLV) and xenotropic murine leukemia virus (XMRV), named the CAE (cytoplasmic accumulation element). The CAE enhanced the cytoplasmic accumulation of viral RNA transcripts and the expression of viral proteins without significantly affecting the stability, splicing, or translation efficiency of the transcripts. Insertion of the CAE sequence also facilitated Rev-independent HIV Gag expression. We found that the CAE sequence interacted with NXF1, whereas disruption of NXF1 ablated CAE function. Thus, the CAE sequence mediates the cytoplasmic accumulation of gammaretroviral transcripts in an NXF1-dependent manner. Disruption of NXF1 expression impaired cytoplasmic accumulations of both spliced and unspliced RNA transcripts of XMRV and MLV, resulting in their nuclear retention or degradation. Thus, our results demonstrate that gammaretroviruses use NXF1 for the cytoplasmic accumulation of both spliced and nonspliced viral RNA transcripts. IMPORTANCE Murine leukemia virus (MLV) has been studied as one of the classic models of retrovirology. Although unspliced host messenger RNAs are rarely exported from the nucleus, MLV actively exports unspliced viral RNAs to the cytoplasm. Despite extensive studies, how MLV achieves this difficult task has remained a mystery. Here, we have studied the RNA export mechanism of MLV and found that (i) the genome contains a sequence which supports the efficient nuclear export of viral RNAs, (ii) the cellular factor NXF1 is involved in the nuclear export of both spliced and unspliced viral RNAs, and, finally, (iii) depletion of NXF1 results in nuclear retention or degradation of viral RNAs. Our study provides a novel insight into MLV nuclear export.
CrossMap: a versatile tool for coordinate conversion between genome assemblies
Zhao, Hao , Sun, Zhifu , Kocher, Jean‐Pierre , Wang, Liguo , Wang, Jing , Huang, Haojie , Sun, Zhifu , Wang, Liguo

Mayo Clinic

Bioinformatics | December 19, 2013 | Volume: 30 | Issue: 7 | Pages: 1006-1007

10.1093/bioinformatics/btt730 | PMID 24351709 Get It

Abstract Motivation: Reference genome assemblies are subject to change and refinement from time to time. Generally, researchers need to convert the results that have been analyzed according to old assemblies to newer versions, or vice versa, to facilitate meta-analysis, direct comparison, data integration and visualization. Several useful conversion tools can convert genome interval files in browser extensible data or general feature format, but none have the functionality to convert files in sequence alignment map or BigWig format. This is a significant gap in computational genomics tools, as these formats are the ones most widely used for representing high-throughput sequencing data, such as RNA-seq, chromatin immunoprecipitation sequencing, DNA-seq, etc. Results: Here we developed CrossMap, a versatile and efficient tool for converting genome coordinates between assemblies. CrossMap supports most of the commonly used file formats, including BAM, sequence alignment map, Wiggle, BigWig, browser extensible data, general feature format, gene transfer format and variant call format. Availability and implementation: CrossMap is written in Python and C. Source code and a comprehensive user’s manual are freely available at: http://crossmap.sourceforge.net/. Contact: Kocher.JeanPierre@mayo.edu or wang.liguo@mayo.edu Supplementary information: Supplementary data are available at Bioinformatics online.
Calculating Sample Size Estimates for RNA Sequencing Data
Hart, Steven N. , Therneau, Terry M. , Zhang, Yuji , Kocher, Jean‐Pierre , Poland, Gregory A. , Hart, Steven N

Mayo Clinic

Journal of Computational Biology | August 20, 2013 | Volume: 20 | Issue: 12 | Pages: 970-978

10.1089/cmb.2012.0283 | PMID 23961961 Get It

Abstract Background: Given the high technical reproducibility and orders of magnitude greater resolution than microarrays, next-generation sequencing of mRNA (RNA-Seq) is quickly becoming the de facto standard for measuring levels of gene expression in biological experiments. Two important questions must be taken into consideration when designing a particular experiment, namely, 1) how deep does one need to sequence? and, 2) how many biological replicates are necessary to observe a significant change in expression? Results: Based on the gene expression distributions from 127 RNA-Seq experiments, we find evidence that 91% ± 4% of all annotated genes are sequenced at a frequency of 0.1 times per million bases mapped, regardless of sample source. Based on this observation, and combining this information with other parameters such as biological variation and technical variation that we empirically estimate from our large datasets, we developed a model to estimate the statistical power needed to identify differentially expressed genes from RNA-Seq experiments. Conclusions: Our results provide a needed reference for ensuring RNA-Seq gene expression studies are conducted with the optimally sample size, power, and sequencing depth. We also make available both R code and an Excel worksheet for investigators to calculate for their own experiments.
A new statistic for identifying batch effects in high-throughput genomic data that uses guided principal component analysis
Reese, Sarah E. , Archer, Kellie J. , Therneau, Terry M. , Atkinson, Elizabeth J. , Vachon, Celine M. , Kocher, Jean‐Pierre , Eckel‐Passow, Jeanette E. , Vachon, Celine M. , Andrade, Mariza de

Mayo Clinic

Bioinformatics | August 19, 2013 | Volume: 29 | Issue: 22 | Pages: 2877-2883

10.1093/bioinformatics/btt480 | PMID 23958724 Get It

Abstract Motivation: Batch effects are due to probe-specific systematic variation between groups of samples (batches) resulting from experimental features that are not of biological interest. Principal component analysis (PCA) is commonly used as a visual tool to determine whether batch effects exist after applying a global normalization method. However, PCA yields linear combinations of the variables that contribute maximum variance and thus will not necessarily detect batch effects if they are not the largest source of variability in the data. Results: We present an extension of PCA to quantify the existence of batch effects, called guided PCA (gPCA). We describe a test statistic that uses gPCA to test whether a batch effect exists. We apply our proposed test statistic derived using gPCA to simulated data and to two copy number variation case studies: the first study consisted of 614 samples from a breast cancer family study using Illumina Human 660 bead-chip arrays, whereas the second case study consisted of 703 samples from a family blood pressure study that used Affymetrix SNP Array 6.0. We demonstrate that our statistic has good statistical properties and is able to identify significant batch effects in two copy number variation case studies. Conclusion: We developed a new statistic that uses gPCA to identify whether batch effects exist in high-throughput genomic data. Although our examples pertain to copy number data, gPCA is general and can be used on other data types as well. Availability and implementation: The gPCA R package (Available via CRAN) provides functionality and data to perform the methods in this article. Contact: reesese@vcu.edu or eckel@mayo.edu Supplementary information: Supplementary data are available at Bioinformatics online.
A Sequence-Based Variation Map of Zebrafish
Patowary, Ashok , Purkanti, Ramya , Singh, Meghna , Chauhan, Rajendra , Singh, Angom Ramcharan, Swarnkar, Mohit Kumar , Torroja, Carlos , Kocher, Jean‐Pierre , Clark, Karl J. , Klee, Eric W. , Ekker, Stephen C. , Scaria, Vinod , Sivasubbu, Sridhar , Singh, Naresh , Pandey, Vikas , Clark, Matthew D. , Stemple, Derek L. , Ekker, Stephen C , Clark, Karl J

Mayo Clinic

Zebrafish | April 16, 2013 | Volume: 10 | Issue: 1 | Pages: 15-20

10.1089/zeb.2012.0848 | PMID 23590399 Get It

Abstract Zebrafish ( Danio rerio ) is a popular vertebrate model organism largely deployed using outbred laboratory animals. The nonisogenic nature of the zebrafish as a model system offers the opportunity to understand natural variations and their effect in modulating phenotype. In an effort to better characterize the range of natural variation in this model system and to complement the zebrafish reference genome project, the whole genome sequence of a wild zebrafish at 39-fold genome coverage was determined. Comparative analysis with the zebrafish reference genome revealed approximately 5.2 million single nucleotide variations and over 1.6 million insertion–deletion variations. This dataset thus represents a new catalog of genetic variations in the zebrafish genome. Further analysis revealed selective enrichment for variations in genes involved in immune function and response to the environment, suggesting genome-level adaptations to environmental niches. We also show that human disease gene orthologs in the sequenced wild zebrafish genome show a lower ratio of nonsynonymous to synonymous single nucleotide variations.
CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model
Wang, Liguo , Park, Hyun Jung , Dasari, Surendra , Wang, Shengqin , Kocher, Jean‐Pierre , Li, Wei , Wang, Liguo

Mayo Clinic

Nucleic Acids Research | January 18, 2013 | Volume: 41 | Issue: 6 | Pages: e74-e74

10.1093/nar/gkt006 | PMID 23335781 Get It